Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Registry for patients treated with ALTO endograft for abdominal aortic aneurysm

Official title: ALTo endogrAft Italian Registry

Run by Azienda Ospedaliera Universitaria Senese · NCT05234892 · Data updated 2026-11-12

This study looks at how well the ALTO stent graft works for people having surgery to fix abdominal aortic aneurysms and what outcomes they experience afterward.

More Abdominal Aortic Aneurysm trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorAzienda Ospedaliera Universitaria Senese
Academic / other
Locations2 sites (Rome and 1 other locations)
StatusRecruiting
StartedJanuary 1, 2022
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedJuly 20, 2023
Trial IDNCT05234892 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old who are scheduled for elective endovascular aneurysm repair using the ALTO endograft.

Probably not a fit

Patients requiring urgent or emergent repair of AAA or those with contraindications to the ALTO endograft will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the intraoperative, peri-operative, and post-operative outcomes of patients undergoing elective repair of abdominal aortic aneurysms (AAA) using the ALTO stent graft. The study will collect data from multiple centers to assess the effectiveness and safety of this innovative endograft device. By analyzing the results from a diverse patient population, the study seeks to provide insights into the performance of the ALTO endograft in various anatomical challenges. The research will focus on long-term outcomes and complications associated with the use of this device.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of the ALTO endograft's effectiveness, potentially leading to improved treatment options for patients with AAA.

How similar studies have gone: While there have been studies on endovascular aneurysm repair, this specific evaluation of the ALTO endograft is relatively novel and has limited published outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Elective AAA patients that should be treated by standard EVAR, according to Endologix Alto endograft device's Instructions For Use;
* Patient is willing to comply with specified follow-up evaluations at the specified times for the duration of the study;
* Patient is \>18 years old;
* Patient, or their legal representative, understands the nature of the procedure and provides written informed consent, prior to enrollment in the study.

Exclusion Criteria:

* EVAR performed in Urgent/Emergent setting;
* Patients treated outside Endologix Alto endograft device's Instructions For Use;
* Patients refusing treatment;
* Patients for whom antiplatelet therapy, anticoagulants or antihypertensive drug are contraindicated;
* Patients with a history of prior life-threatening contrast medium reaction;
* Life expectancy of less than follow-up period.

AAA: abdominal aortic aneurysm; EVAR: abdominal endovascular aneurysm

Where it's running

  • University La Sapienza of Rome
    Rome, Italy
    Recruiting
  • University of Siena
    Siena, Italy
    Recruiting

Study contacts

  • Principal investigator: Gianmarco de Donato, MD, PhD — University of Siena
  • Study coordinator: Gianmarco de Donato, MD, PhD
  • Email: dedonato@unisi.it
  • Phone: +390577585123

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.